and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock. For Zevia, rising earnings estimates and the ...

Alternative valuation techniques confirm my suspicion of market overvaluation, leading me to rate Zevia as a "Sell" for the first time. I was kindly asked by the readers to follow up on my review ...

Zevia currently expects fourth quarter 2024 net ... as well as pockets of value. We sell different types of products and services to both investment professionals and individual investors.

During the company's earnings conference call, Zevia (ZVIA) management expressed confidence in the strong sell-through it saw ...

Overall, this was a mediocre quarter for Zevia PBC. Zevia is down 11.8% since the beginning of the year, and at $4.05 per share, it is trading 12.7% below its 52-week high of $4.64 from January 2025.

Monday announced preliminary results, reporting net sales of approximately $39.5 million for the fourth quarter, ...

Zevia PBC engages in the development, marketing, sales, and distribution of zero-calorie diet sodas. Its products include soda, energy, organix tea, mixers, kidz drinks, and sparkling water. The ...

In total, the ad garnered over 292 million impressions, serving to bring Zevia’s (ZVIA) brand voice and unique positioning to a much broader audience. We plan to continue to opportunistically ...

Zevia PBC engages in the development, marketing, sales, and distribution of zero-calorie diet sodas. Its products include soda, energy, organix tea, mixers, kidz drinks, and sparkling water.

On Monday, Zevia PBC shares experienced a significant drop, plunging as much as 19% during intraday trading, marking the steepest decline since November 13. The nosedive in share price came after ...

Zevia currently expects fourth quarter 2024 net sales of approximately $39.5 million, at the high end of its previous outlook. Adjusted EBITDA loss (1) is now expected to be $3.9 million to $4.2 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.